Text Search: Search by:

Refine your search with filters

Year:

All

Congress Abstracts

Tools & Skills

Publications

Congress Presentations

Videos & Podcasts

Quicksearch

P324: Comparative short and long-term efficacy of infliximab and adalimumab in patients with ulcerative colitis refractory to corticosteroids: a retrospective studyECCO '16 Amsterdam

Year: 2016

Authors:

N. Yoshimura*, M. Sako, M. Takazoe

Tokyo Yamate Medical Centre, Department of Internal Medicine, Tokyo, Japan

P325: Efficacy, safety, and long-term outcome of endoscopic dilation therapy for stricturing Crohn’s disease of the upper gastrointestinal tract: a combined analysis of 127 endoscopic balloon dilation proceduresECCO '16 Amsterdam

Year: 2016

Authors:

D. Bettenworth*¹, M. M. Mücke¹, A. Singh², R. Lopez³, F. Rieder^{4, 5}

¹University Hospital Münster, Department of Medicine B, Münster, Germany, ²Cleveland Clinic Foundation, Department of Hospital Medicine, Cleveland, Ohio, United States, ³Cleveland Clinic Foundation, Department of Quantitative Health Sciences, Cleveland, Ohio, United States, ⁴Cleveland Clinic Foundation, Department of Gastroenterology, Hepatology & Nutrition, Digestive Disease Institute, Cleveland, Ohio, United States, ⁵Cleveland Clinic Foundation, Department of Pathobiology, Cleveland, Ohio, United States

P326: Validation of CUCQ-8 Questionnaire for Quality of Life Assessment in IBD PatientsECCO '16 Amsterdam

Year: 2016

Authors:

C. McGinley*¹, C. Mowat², M. Groome², J. Todd², N. Reynolds²

¹University of Dundee, Dundee, United Kingdom, ²Ninewells Hospital and Medical School, Department of Gastroenterology, Dundee, United Kingdom

Year: 2016

Authors:

L. Carvalho Lourenço*, V. Anapaz, A. M. Oliveira, J. Branco, M. Cardoso, C. Graça Rodrigues, L. Santos, D. Horta, A. Martins, J. Reis

Hospital Prof Dr Fernando Fonseca, Serviço de Gastrenterologia, Amadora, Portugal

P328: Factors related to short- and long-term treatment results and usefulness of infliximab for refractory ulcerative colitisECCO '16 Amsterdam

Year: 2016

Authors:

Y. Takada*, S. Yasukawa, R. Amano, M. Yasaka, N. Takatsu, Y. Yano, F. Hirai

Fukukuoka University Chikushi hospital, Chikushino-shi, Japan

P329: Infliximab biosimilar in the treatment of inflammatory bowel disease: a Japanese single-cohort observational studyECCO '16 Amsterdam

Year: 2016

Authors:

S. Hamanaka*, T. Nakagawa, H. Koseki, T. Sakurai, T. Taida, K. Okimoto, K. Saito, D. Maruoka, T. Matsumura, T. Katsuno, M. Arai, O. Yokosuka

Graduate School of Medicine, Chiba University, Department of Gastroenterology and Nephrology, Chiba City, Japan

P330: Vitamin D insufficiency in patients with inflammatory bowel diseaseECCO '16 Amsterdam

Year: 2016

Authors:

M. d. C. Martos Plasencia*, C. Verdejo Gil, R. H. Lorente Poyatos, E. De la Santa Belda, M. Peña Gómez, R. Salmoral Luque, B. López Viedma, J. Olmedo Camacho

University Hospital of Ciudad Real, Gastroenterology and Hepatology Department, Ciudad Real, Spain

P331: Allopurinol and azathioprine co-therapy or thioguanine dose splitting: shifting the shunters in the mercaptopurine pathway in a paediatric inflammatory bowel disease population—a single-centre experienceECCO '16 Amsterdam

Year: 2016

Authors:

S. Chadokufa*¹, A. Lozinsky Rolnik², S. Sider¹, N. Acton³, B. Huggett³, N. Shah⁴, F. Kiparissi¹

¹Great Ormond Street Hospital, Gastro, London, United Kingdom, ²Great Ormond Street Hospital, Gastro, LONDON, United Kingdom, ³Great Ormond Street, London, United Kingdom, ⁴Great Ormond Street, Gastro, London, United Kingdom

P332: Influence of mesalamine maintenance therapy on progression of ulcerative proctitis in KoreaECCO '16 Amsterdam

Year: 2016

Authors:

Y. S. Choi¹, W. J. Kim*², H.-J. Jung³, J. K. Kim¹, K.-H. Song³

¹Daehang Hospital, Gastroenterology, Seoul, South Korea, ²Soonchunhyang University Hospital, Gastroenterology, Gumi-si, South Korea, ³Daehang Hospital, Surgery, Seoul, South Korea

P333: Long-term efficacy and safety of thiopurines in patients with steroid-dependent ulcerative colitis: a retrospective investigationECCO '16 Amsterdam

Year: 2016

Authors:

Y. Yokoyama*, T. Sato, M. Kawai, Y. Kita, K. Kamikozuru, T. Miyazaki, M. Iimuro, N. Hida, S. Nakamura

Hyogo College of Medicine, Department of Inflammatory Bowel Disease, Division of Internal Medicine, Nishinomiya, Japan

P334: Evolution of a long-term follow-up cohort of Crohn’s disease with complex perianal fistula: from antibiotic to combined AZA and anti-TNF based treatment ending up clinical and radiological healing with or without stomaECCO '16 Amsterdam

Year: 2016

Authors:

Y. Erzin*, K. Ercaliskan, I. Hatemi, K. Atay, S. Bozcan, N. Demir, A. F. Celik

Istanbul University Cerrahpasa Medical School, Gastroenterology, Istanbul, Turkey

P335: Cancer recurrence with immunosuppressive therapy in immune-mediated diseases: a systematic review and meta-analysisECCO '16 Amsterdam

Year: 2016

Authors:

E. Shelton*¹, D. Laharie², F. Scott³, R. Mamtani⁴, J. Lewis⁴, J.-F. Colombel⁵, A. Ananthakrishnan¹

¹Massachusetts General Hospital, Boston, Massachusetts, United States, ²University-Bordeaux, Bordeaux, France, ³University of Pennsylvania, Philadelphia, Pennsylvania, United States, ⁴University of Pennsylvania Perelman School of Medicine, Division of Gastroenterology, Philadelphia, Pennsylvania, United States, ⁵Mount Sinai, Icahn School of Medicine, New York, New York, United States

P336: French prospective, longitudinal observational study of the therapeutic management of mild to moderate ulcerative colitis (Optimum study): follow-up at 3 yearsECCO '16 Amsterdam

Year: 2016

Authors:

S. Nahon*¹, G. Bonnaud², F. Bahbah³

¹Centre Hospitalier Le Raincy, Montfermeil, France, ²Ambroise Paré Private hospital, IBD Unit, Toulouse, France, ³Ferring Pharmaceuticals, Gentilly, France

P337: Anti-TNFalpha therapy is associated with rapid reduction of circulating monocyte numbers and blunted monocyte pro-inflammatory response in patients with Crohn’s diseaseECCO '16 Amsterdam

Year: 2016

Authors:

S. Slevin*¹, C. Dennedy², A. Ribeiro¹, R. Ceredig¹, M. Griffin¹, L. Egan²

¹National University of Ireland Galway, REMEDI, Galway, Ireland, ²National University of Ireland Galway, Pharmacology and Therapeutics, Galway, Ireland

P338: Rate and predictors of mucosal healing in patients with ulcerative colitis treated with thiopurines: results of a multicentric cohort studyECCO '16 Amsterdam

Year: 2016

Authors:

C. Prieux-Klotz*¹, S. Nahon², A. Amiot³, L. Sinayoko⁴, C. Galéano-Cassaz⁵, S. Chaussade¹, P. Lahmek⁶, V. Abitbol¹

¹C.H.U. Cochin, Paris, France, ²C.H. Le Raincy Montfermeil, Montfermeil, France, ³C.H.U. Henri Mondor, Créteil, France, ⁴H.I.A. Bégin, Saint Mandé, France, ⁵H.I.A. Val de Grâce, Paris, France, ⁶C.H. Emile Roux, Limeil-Brévannes, France

P339: The efficacy of intravenous iron therapy in IBD patients with active disease is not influenced by the degree of inflammatory activityECCO '16 Amsterdam

Year: 2016

Authors:

A. Walper*¹, A. Dignass^{2, 3}, J. Stein^{3, 4}

¹Medice Arzneimittel GmbH, Iserlohn, Germany, ²Agaplesion Markus Krankenhaus, Frankfurt/Main, Germany, ³Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, ⁴DGD Clinics Sachsenhausen, Frankfurt/Main, Germany

P340: Postoperative clinical recurrence in Crohn’s disease patients: the Practicrohn studyECCO '16 Amsterdam

Year: 2016

Authors:

E. Domènech*¹, V. García², M. D. Martín Arranz³, M. Barreiro-de Acosta⁴, A. Gutiérrez⁵, L. Cea-Calvo⁶, C. Romero⁶, B. Juliá⁶

¹Hospital Universitari Germans Trias i Pujol and CIBERehd, Gastroenterology Unit, Badalona, Spain, ²Hospital Universitario Reina Sofia, Unidad Clinica de Aparato Digestivo, Cordoba, Spain, ³Hospital Universitario La Paz, Gastroenterology Unit, Madrid, Spain, ⁴Complejo Hospitalario Universitario de Santiago, Gastroenterology Unit, Santiago de Compostela, Spain, ⁵Hospital General Universitario Alicante, Gastroenterology Unit, Alicante, Spain, ⁶MSD Spain, Medical Department, Madrid, Spain

P341: Analytical performance of a new iPhone-based patient monitoring system comparable to ELISA for measuring faecal calprotectin in inflammatory bowel disease patientsECCO '16 Amsterdam

Year: 2016

Authors:

K. F. Wintgens*¹, A. A. Wulandari², A. Dignass^{3, 4}, F. Hartmann^{3, 4}, J. Stein^{2, 3}

¹Immundiagnostik AG, Bensheim, Germany, ²DGD Clinics Sachsenhausen, Frankfurt/Main, Germany, ³Interdisciplinary Crohn Colitis Centre Rhein-Main, Frankfurt/Main, Germany, ⁴Agaplesion Markus Krankenhaus, Frankfurt/Main, Germany

P342: Tryptophan as a biomarker for the course of IBD and anti-TNF α responseECCO '16 Amsterdam

Year: 2016

Authors:

B. Brandt*¹, S. Nikolaus², N. Al-Massad², J. Bethge², D. Schuldt², S. Szymczak³, F. Thieme⁴, G. H. Waetzig⁵, M. Krawczak³, R. Junker⁴, P. Rosenstiel⁶, S. Schreiber²

¹UKSH Kiel, Department of Internal Medicine I, Kiel, Germany, ²UKSH, Department of Internal Medicine I, Kiel, Germany, ³UKSH, Institute of Medical Informatics and Statistics, Kiel, Germany, ⁴UKSH, Institute of Clinical Chemistry, Kiel, Germany, ⁵Conaris Research Institute AG, Kiel, Germany, ⁶UKSH, Institute of Clinical Molecular Biology, Kiel, Germany

P343: The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease and the relationship with biochemical markers of disease activityECCO '16 Amsterdam

Year: 2016

Authors:

K. Diederen¹, D. Hoekman*¹, T. Hummel², T. de Meij³, B. Koot¹, M. Tabbers¹, A. Vlieger⁴, A. Kindermann¹, M. Benninga¹

¹Academic Medical Centre (AMC), Department of Paediatric Gastroenterology, Amsterdam, Netherlands, ²Medisch Spectrum Twente, Department of Paediatrics, Enschede, Netherlands, ³VU University Medical Centre, Department of Paediatric Gastroenterology, Amsterdam, Netherlands, ⁴St. Antonius Hospital, Department of Paediatrics, Nieuwegein, Netherlands